Seed Therapeutics
A winner of the Nobel Prize in Chemistry in 2004 and co-winner of the Lasker Award in 2000, Dr. Hershko was the first researcher to describe the ubiquitin system responsible for the regulated degradation of proteins within the cell. This discovery represented a breakthrough in research on cancer, degenerative diseases in the brain, and many other disorders. He is currently a Distinguished Professor in the Department of Biochemistry at Technion – Israel Institute of Technology in Haifa, Israel and has been an adjunct professor of Pathology at the NYU School of Medicine since 2002.
This person is not in the org chart
This person is not in any offices
Seed Therapeutics
Seed Therapeutics is pioneering the science of improving human health by creating “molecular glues”: novel therapeutics that degrade disease-causing proteins that have heretofore remained “undruggable.”